Skip to main content

Combination of sST2 and BNP in Predicting the Mortality of ST-Elevation Myocardial Infarction

  • Conference paper
  • First Online:
7th International Conference on the Development of Biomedical Engineering in Vietnam (BME7) (BME 2018)

Part of the book series: IFMBE Proceedings ((IFMBE,volume 69))

  • 1236 Accesses

Abstract

Serum levels of ST2 are associated with prognosis in non-ischemic heart failure, but the predictive value of ST2 in patients with ST elevation myocardial infarction is unknown. Methods The study included 38 STEMI patients at Interventional Cardiology department of Cho Ray hospital. Correlation analysis was used to identify the relationship between the cardiac outcomes within 30 days from the onset of chest pain and sST2 value. Results ST2 levels were measured in serum from 38 patients with STEMI. Baseline levels of ST2 were significantly higher in those patients who died (<35 ng/mL vs. >35 ng/mL, P = 0.01) or developed new congestive heart failure (<35 ng/mL vs. >35 ng/mL, P = 0.002) by 30 days. In an analysis of outcomes at 30 days by ST2 quartiles, both death (P = 0.01) and the combined death/heart failure end point (p = 0.001) showed a significant graded association with levels of ST2. Furthermore, when sST2 > 35 ng/mL and BNP > 500 pg/mL showed a tightly relationship with cardiac outcomes within 30 days (P < 0.0001). Conclusions Serum levels of the interleukin-1 receptor family member ST2 predict mortality and heart failure in patients with STEMI. These data suggest that ST2 and BNP are the useful biomarker in short-term prognosis of cardiac events in STEMI.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 129.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 169.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Thygesen, K., Alpert, J.S., Jaffe, A.S.: Third universal definition of myocardial infarction. Eur. Hear. J. 33, 2551–2567 (2012). https://doi.org/10.1093/eurheartj/ehs184

  2. O’Gara, P.T., Kushner, F.G., Ascheim, D.D.: ACCF/AHA guideline for the management of st-elevation myocardial infarction, a report of the american college of cardiology foundation/american heart association task force on practice guidelines. Circulation 127 (2013). https://doi.org/10.1161/CIR.0b013e3182742cf6

  3. Shimpo, M., Morrow, D.A., Weinberg, E.O, Sabatine, M.S., Murphy, S.A., Antman, E.M., Lee, R.T.: Serum levels of the interleukin-1 receptor family member ST2 predict mortality and clinical outcome in acute myocardial infarction. Circulation 109, 2186–2190 (2004). https://doi.org/10.1161/01.CIR.0000127958.21003.5A

  4. Sabatine, M.S., Morrow D.A., Higgins L., MacGillivray C., Guo W., Bode C., Rifai N., Cannon C.P., Gerszten R.E., Lee R.T.: Complementary roles for biomarkers of biomechanical strain ST2 and N-terminal prohormone B-type natriuretic peptide in patients with ST-elevation myocardial infarction. Circulation 117, 1936–1944 (2008). https://doi.org/10.1161/CIRCULATIONAHA.107.728022

  5. Brown, A.M., Wu, A.H.B., Clopton, P., Robey, J.L., Hollander, J.E.: ST2 in emergency department chest pain patients with potential acute coronary syndromes. Ann. Emerg. Med. 50, 153–158 (2007). https://doi.org/10.1016/j.annemergmed.2007.02.015

  6. Weinberg, E.O., Shimpo, M., De Keulenaer, G.W., MacGillivray, C., Tominaga, S., et al.: Expression and regulation of ST2, an interleukin-1 receptor family member, in cardiomyocytes and myocardial infarction. Circulation 106, 2961–2966. (2002)

    Google Scholar 

  7. Bartunek, J., Delrue, L., Van Durme, F., et al.: Nonmyocardial production of ST2 protein in human hypertrophy and failure is related to diastolic load. J. Am. Coll. Cardiol. 52(25), 2166–2174 (2008). https://doi.org/10.1016/j.jacc.2008.09.027

  8. Dhillon, O.S., Narayan, H.K., Khan, S.Q., Kelly, D., Quinn, P.A., Squire, I.B., Davies, J.E., Ng, L.L.: Pre-discharge risk stratification in unselected STEMI: is there a role for ST2 or its natural ligand IL-33 when compared with contemporary risk markers. Int. J. Cardiol. 167, 2182–2188 (2013). https://doi.org/10.1016/j.ijcard.2012.05.073

  9. Granger, C.B., Goldberg, R.J., Dabbous, O., et al.: Global Registry of acute coronary events investigators. Predictors of hospital mortality in the global registry of acute coronary events. Arch. Intern. Med. 163, 2345–2353 (2003).  https://doi.org/10.1001/archinte.163.19.2345

Download references

Conflict of Interest

I declare that I have no conflict of interest.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Hoang Anh Tien .

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2020 Springer Nature Singapore Pte Ltd.

About this paper

Check for updates. Verify currency and authenticity via CrossMark

Cite this paper

Tien, H.A., Truc, T.T.T., Nhan, V.T. (2020). Combination of sST2 and BNP in Predicting the Mortality of ST-Elevation Myocardial Infarction. In: Van Toi , V., Le, T., Ngo, H., Nguyen, TH. (eds) 7th International Conference on the Development of Biomedical Engineering in Vietnam (BME7). BME 2018. IFMBE Proceedings, vol 69. Springer, Singapore. https://doi.org/10.1007/978-981-13-5859-3_113

Download citation

  • DOI: https://doi.org/10.1007/978-981-13-5859-3_113

  • Published:

  • Publisher Name: Springer, Singapore

  • Print ISBN: 978-981-13-5858-6

  • Online ISBN: 978-981-13-5859-3

  • eBook Packages: EngineeringEngineering (R0)

Publish with us

Policies and ethics